Agentic coding can build a working prototype in an afternoon. Whether it can build a product you'd trust in production, alone, without a team, is a different question. That gap is what this article is about.

The global AI market was estimated at $371.71 billion in 2025 and is projected to reach $2,407.02 billion by 2032, growing at a 30.6% CAGR, according to MarketsandMarkets. That scale has attracted a large and diverse field of AI development companies, which makes choosing the right partner harder.

Gartner expects over 40% of agentic AI projects to be canceled by the end of 2027. Across the healthcare industry, the gap is just as stark, with only 21% of organizations reporting mature governance for agentic AI, even as 74% expect to use AI agents by 2027. Production lags far behind.

Your clinicians didn't go to medical school to fight with insurance forms. Yet that's where a huge share of their day goes.

By February 2026, 41% of all code written globally was AI-generated. A quarter of Y Combinator's latest batch had codebases that were 95% AI-written. Yet an independent randomized trial found that senior developers were actually 19% slower when using AI tools, while feeling 20% faster.

In February 2025, researchers showed that data from 20,000+ GitHub repositories that were later made private could still be surfaced via Copilot. This impacted 16,000+ organizations. That incident is a clean example of the shadow AI problem: employees adopt powerful AI tools fast, but security teams often can’t see what’s being used in the browser or what data is flowing into it.

Did you know that 93% of healthcare organizations faced a cyberattack in the past year? Moreover, the average cost of a data breach in healthcare now tops $9.77 million, according to the Ponemon Healthcare Cybersecurity Report.

AI tools can now generate working software in minutes. A founder can describe an idea, press enter, and get a prototype the same day. The speed feels revolutionary, but many teams hit the same wall a few weeks later: the code works in a demo but breaks under real-world circumstances.

Seventy percent of companies are testing AI, yet fewer than one in three see real financial returns. Many teams start with excitement and end with a stalled pilot, unclear ROI, or a system that works in a demo but fails in production.

More than 80% of enterprises are expected to use generative AI in production by the end of 2026. Yet many AI initiatives still stall before they deliver measurable value. Budgets are approved, models are tested, and demos look impressive. But once exposed to real users, the results often fall short.

Get the inside scoop on industry news, product updates, and emerging trends, empowering you to make more informed decisions and stay ahead of the curve.